​
​

Valneva SE (VALN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Valneva SE Revenue Highlights

Latest Revenue (Y)

$153.70M

Latest Revenue (Q)

$32.75M

Main Segment (Y)

IXIARO

Main Geography (Y)

UNITED STATES

Valneva SE Revenue by Period

Valneva SE Revenue by Year

DateRevenueChange
2023-12-31$153.70M-57.46%
2022-12-31$361.30M3.80%
2021-12-31$348.08M215.52%
2020-12-31$110.32M-12.58%
2019-12-31$126.20M11.64%
2018-12-31$113.03M7.35%
2017-12-31$105.29M11.94%
2016-12-31$94.06M20.04%
2015-12-31$78.36M112.22%
2014-12-31$36.92M21.28%
2013-12-31$30.45M787.35%
2012-12-31$3.43M-66.57%
2011-12-31$10.26M22.25%
2010-12-31$8.39M171.16%
2009-12-31$3.10M-9.42%
2008-12-31$3.42M294.69%
2007-12-31$866.00K-62.82%
2006-12-31$2.33M-22.65%
2005-12-31$3.01M-

Valneva SE generated $153.70M in revenue during NA 2023, up -57.46% compared to the previous quarter, and up 135.98% compared to the same period a year ago.

Valneva SE Revenue by Quarter

DateRevenueChange
2024-03-31$32.75M-21.83%
2023-12-31$41.90M10.05%
2023-09-30$38.07M-5.38%
2023-06-30$40.23M20.08%
2023-03-31$33.51M-69.92%
2022-12-31$111.40M-28.90%
2022-09-30$156.68M119.51%
2022-06-30$71.38M226.69%
2022-03-31$21.85M-92.15%
2021-12-31$278.24M1145.13%
2021-09-30$22.35M-7.99%
2021-06-30$24.29M4.61%
2021-03-31$23.22M-54.90%
2020-12-31$51.47M370.46%
2020-09-30$10.94M-13.76%
2020-06-30$12.69M-63.98%
2020-03-31$35.22M-21.39%
2019-12-31$44.80M66.65%
2019-09-30$26.88M36.79%
2019-06-30$19.65M-43.61%
2019-03-31$34.86M0.43%
2018-12-31$34.71M79.25%
2018-09-30$19.36M-27.98%
2018-06-30$26.88M-16.20%
2018-03-31$32.08M10.82%
2017-12-31$28.95M28.76%
2017-09-30$22.48M-11.54%
2017-06-30$25.42M-10.65%
2017-03-31$28.44M9.27%
2016-12-31$26.03M41.51%
2016-09-30$18.39M-28.95%
2016-06-30$25.89M9.02%
2016-03-31$23.75M13.36%
2015-12-31$20.95M3.68%
2015-09-30$20.20M8.68%
2015-06-30$18.59M-0.11%
2015-03-31$18.61M61.92%
2014-12-31$11.49M3.81%
2014-09-30$11.07M37.16%
2014-06-30$8.07M28.55%
2014-03-31$6.28M-29.26%
2013-12-31$8.88M-35.79%
2013-09-30$13.83M97.37%
2013-06-30$7.00M850.47%
2013-03-31$737.00K-17.65%
2012-12-31$895.00K-13.28%
2012-09-30$1.03M-

Valneva SE generated $32.75M in revenue during Q1 2024, up -21.83% compared to the previous quarter, and up 29.40% compared to the same period a year ago.

Valneva SE Revenue Breakdown

Valneva SE Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
DUKORAL$29.77M$17.34M$2.40M
IXIARO$73.48M$41.37M$45.10M
Third Party Products$35.67M$26.55M-
Others Products$3.09M--
Lyme Candidate Vaccine--$14.30M
COVID--$253.31M

Valneva SE's latest annual revenue breakdown by segment (product or service), as of Dec 23: IXIARO (51.74%), Third Party Products (25.12%), DUKORAL (20.96%), and Others Products (2.18%).

Valneva SE Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22
Other Europe$9.34M$6.25M
Nordics$12.70M$8.56M
GERMANY$13.50M$20.34M
FRANCE$5.87M$2.63M
CANADA$28.19M$18.90M
UNITED STATES$32.96M$21.99M
Rest Of World$16.31M$11.48M
AUSTRIA$14.58M$13.75M

Valneva SE's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (24.70%), CANADA (21.13%), Rest Of World (12.22%), AUSTRIA (10.93%), GERMANY (10.12%), Nordics (9.51%), Other Europe (7.00%), and FRANCE (4.40%).

Valneva SE Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VALNValneva SE$153.70M$32.75M
SAGESage Therapeutics$86.45M$11.87M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
STOKStoke Therapeutics$8.78M$4.89M
INBXInhibrx Biosciences$1.80M-
OPTOpthea$108.41K$61.27K
ANEBAnebulo Pharmaceuticals--
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
RLYBRallybio-$299.00K
CNTBConnect Biopharma--
NCNANuCana--
TILInstil Bio--
GRPHLENZ Therapeutics--
ELYMEliem Therapeutics--
NLTXNeurogene--
MLYSMineralys Therapeutics--
THRDThird Harmonic Bio--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--
SLSSELLAS Life Sciences Group--
NUVBNuvation Bio-$727.00K
TYRATyra Biosciences--

VALN Revenue FAQ

What is Valneva SE’s yearly revenue?

Valneva SE's yearly revenue for 2023 was $153.7M, representing a decrease of -57.46% compared to 2022. The company's yearly revenue for 2022 was $361.3M, representing an increase of 3.80% compared to 2021. VALN's yearly revenue for 2021 was $348.08M, representing an increase of 215.52% compared to 2020.

What is Valneva SE’s quarterly revenue?

Valneva SE's quarterly revenue for Q1 2024 was $32.75M, a -21.83% decrease from the previous quarter (Q4 2023), and a -2.25% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $41.9M, a 10.05% increase from the previous quarter (Q3 2023), and a -62.39% decrease year-over-year (Q4 2022). VALN's quarterly revenue for Q3 2023 was $38.07M, a -5.38% decrease from the previous quarter (Q2 2023), and a -75.70% decrease year-over-year (Q3 2022).

What is Valneva SE’s revenue growth rate?

Valneva SE's revenue growth rate for the last 3 years (2021-2023) was -55.84%, and for the last 5 years (2019-2023) was 21.79%.

What are Valneva SE’s revenue streams?

Valneva SE's revenue streams in c 23 are DUKORAL, IXIARO, Third Party Products, and Others Products. DUKORAL generated $29.78M in revenue, accounting 20.96% of the company's total revenue, up 71.76% year-over-year. IXIARO generated $73.48M in revenue, accounting 51.74% of the company's total revenue, up 77.62% year-over-year. Third Party Products generated $35.68M in revenue, accounting 25.12% of the company's total revenue, up 34.39% year-over-year. Others Products generated $3.09M in revenue, accounting 2.18% of the company's total revenue

What is Valneva SE’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Valneva SE was IXIARO. This segment made a revenue of $73.48M, representing 51.74% of the company's total revenue.